Trials / Completed
CompletedNCT05915884
The Triglyceride/Glucose Index and SGLT-2 Inhibitors
Investigation of the Triglyceride/Glucose Index in Diabetic Patients Using SGLT-2 Inhibitor
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (actual)
- Sponsor
- Samsun Education and Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study was designed to evaluate the change in triglyceride glucose index, one of the atherosclerotic markers, in patients with type 2 DM followed in the Internal Medicine Clinic of Samsun University, Samsun Training, and Research Hospital. Methods: The data of the patients who were followed up for at least 3 months by making a retrospective file review will be recorded and analyzed. It is planned to start the study following the ethics committee's approval.
Detailed description
The data of all patients who applied to Samsun Training and Research Hospital Internal Medicine outpatient clinic for 12 months in 2022 and were started on SGLT-2 inhibitor will be examined. According to the inclusion and exclusion criteria stated below, the patients will be evaluated and the data of the patients admitted to the study will be analyzed. The triglyceride glucose index of the patients before starting the SGLT-2 injection and the trig/glucose index at the end of 3 months of treatment will be calculated by the researchers using the data in the system. No additional blood tests or laboratory analyses will be performed on the patients. Triglyceride, glucose, and glycosylated hemoglobin values were checked at the beginning of the treatment and at the 3rd-month follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | SGLT-2 inhibitors | This study is an observational study. It is not planned to do an interventional activity. |
Timeline
- Start date
- 2023-06-10
- Primary completion
- 2023-10-28
- Completion
- 2024-01-28
- First posted
- 2023-06-23
- Last updated
- 2024-04-26
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05915884. Inclusion in this directory is not an endorsement.